In the ever-evolving landscape of pharmaceutical research, identifying and securing reliable sources for key chemical intermediates is paramount. Among these vital compounds, 3-Cyano-1,2,4-triazole, identified by its CAS number 3641-10-9, stands out as a particularly important building block, especially in the synthesis of antiviral agents.

The structure of 3-Cyano-1,2,4-triazole, a heterocyclic compound featuring a triazole ring with a cyano group, lends itself to diverse chemical transformations. Its utility is primarily recognized in the development of active pharmaceutical ingredients (APIs) that combat viral infections. Researchers actively seek this compound for its potential to be incorporated into novel drug candidates, aiming to enhance efficacy and broaden the spectrum of activity against various viruses.

For R&D scientists and procurement managers, understanding the properties and sourcing of such intermediates is crucial. 3-Cyano-1,2,4-triazole typically presents as a white powder or crystals, with a melting point in the range of 185-187°C. Its molecular formula is C3H2N4, and it has a molecular weight of 94.07 g/mol. These physical and chemical characteristics are essential for accurate formulation and reaction planning.

When considering the purchase of this intermediate, identifying a reputable manufacturer and supplier is key. Companies specializing in fine chemical intermediates, particularly those based in China, often provide competitive pricing and consistent quality. Procurement professionals looking to buy 3-Cyano-1,2,4-triazole should prioritize suppliers who can offer high purity (often exceeding 97%) and guarantee stable supply chains. This ensures that research projects and manufacturing processes are not interrupted by material shortages or quality issues.

The synthesis of antiviral agents often involves multi-step organic synthesis pathways where 3-Cyano-1,2,4-triazole plays a pivotal role. Its specific reactivity allows for precise chemical modifications, leading to the creation of targeted drug molecules. The demand for such intermediates is directly linked to the progress in antiviral drug discovery, making it a valuable commodity for the global pharmaceutical industry.

For businesses seeking to secure their supply of this essential component, exploring options from established manufacturers is advisable. The ability to obtain samples for testing and to discuss bulk order pricing is a standard part of the procurement process. Ultimately, the efficient and cost-effective acquisition of high-quality 3-Cyano-1,2,4-triazole from a trusted chemical manufacturer is a strategic advantage for any company engaged in pharmaceutical innovation.